Document Details
Form
Filing Date
May 23, 2023
Document Date
May 17, 2023
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.